| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Sep 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 186.17K | 216.07K | 376.56K | 463.42K | 611.54K | 807.13K |
| Gross Profit | 117.73K | 168.18K | 336.29K | 416.24K | 476.39K | 530.71K |
| EBITDA | -255.65K | -210.78K | 127.21K | 152.35K | 142.35K | 192.34K |
| Net Income | -280.20K | -240.22K | 26.43K | 40.32K | 34.72K | 83.57K |
Balance Sheet | ||||||
| Total Assets | 367.77K | 773.76K | 694.67K | 804.17K | 887.33K | 917.59K |
| Cash, Cash Equivalents and Short-Term Investments | 106.33K | 565.15K | 336.38K | 329.79K | 466.62K | 391.78K |
| Total Debt | 25.29K | 34.42K | 50.26K | 204.39K | 294.78K | 223.73K |
| Total Liabilities | 172.31K | 468.95K | 153.80K | 263.51K | 390.60K | 462.55K |
| Stockholders Equity | 195.46K | 304.81K | 540.88K | 540.66K | 496.74K | 455.04K |
Cash Flow | ||||||
| Free Cash Flow | -147.88K | 249.16K | 87.59K | -30.43K | 179.98K | 163.90K |
| Operating Cash Flow | -147.99K | 251.69K | 87.59K | -30.43K | 179.98K | 163.90K |
| Investing Cash Flow | 2.74K | -2.53K | 0.00 | 0.00 | 0.00 | 0.00 |
| Financing Cash Flow | -14.95K | -20.39K | -81.00K | -106.40K | -108.53K | -100.64K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
69 Neutral | £21.05B | 22.16 | 5.29% | 4.42% | -2.53% | 24.52% | |
67 Neutral | £661.78M | 13.30 | 13.77% | 2.23% | 11.95% | 20.69% | |
63 Neutral | £26.56B | 7.41 | -8.37% | 3.74% | 16.15% | -279.78% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
57 Neutral | £3.94B | ― | -35.13% | ― | ― | ― | |
50 Neutral | £400.00K | -0.92 | -112.02% | ― | -42.62% | -1023.08% | |
44 Neutral | £18.31M | -9.06 | -2.48% | ― | -2.66% | 86.10% |